News

In pediatric cataract surgery, use of an ocular sealant not only also helps prevent wound leakage but also provides extra protection against eye rubbing and wound manipulation.

A pilot study suggests that using subthreshold photostimulation with a 577-nm PASCAL yellow laser is an effective and safe option for central serous chorioretinopathy.

Long-term cone functional rescue was achieved in dogs with achromatopsia AAV vectors containing codon-optimized human CNGB3 and an improved promoter, which may be a stepping stone to treating achromatopsia in humans.

Prof. Fujikado presents his research, which demonstrated the surgical feasibility and safety of a newly developed, dual-array, suprachoroidal-transretinal stimulation prosthesis in animals. The dual-array design was able to activate retinal neurons and optic nerve axons. Findings indicate the future possibility of activating of a larger visual field with the prosthesis.

Some medical specialties are exploring the possibility of abolishing recertification examinations every 10 years in favor of other alternatives. Is ophthalmology next?

Rules can serve as invaluable guidelines for the future, as they are lessons learned from experience.

In this third of a four-part column, Arun C. Gulani, MD, continues the discussion on staged cataract surgery.

The time for refractive surgery for special needs children seems to be at hand, considering that advancements in laser and IOL technologies have been proven to be efficacious. Correcting a special needs child’s vision can reduce fearfulness and improve their behavioral challenges.

Functional optical coherence tomography characterizing global and local circulation in the retina and optic nerve head shows promise for improving the diagnostic and prognostic evaluation of glaucoma.

Low perfusion pressure is a risk factor for glaucoma. However, understanding the role of perfusion pressure in the disease must be clarified.

Running an effective PR campaign can be a vital part of growing a practice, but all the work that goes into it can also be fun.

Julie Gough-Nelson gives her advice on celebrating national health observances in your practice.

Epimacular brachytherapy does not look promising as a treatment for previously-treated neovascular age-related macular degeneration (AMD), investigators say.

In her latest blog, Donna Suter gives advice on getting the whole office on board to transitioning into a paperless office.

In his debut blog, Joshua Mali, MD, gives advice to his fellow residents on how to secure a stellar ophthalmic career.

New Ohr Pharmaceuticals formulation of topical squalamine was found to improve anti-VEGF effectiveness for the treatment of retinal vein occlusion.

A 5-year study of the implantable miniature telescope for bilateral, end-stage age-related macular degeneration found positive results with a few complications.

A new possible therapy for vitreomacular adhesion and vitreomacular traction had positive results in a phase II trial.

Ranibizumab provided improvements in visual acuity and DR that were stable over the long term when the drug was administered on an as-needed regimen to patients with diabetic macular edema in the RIDE and RISE trials.

Patients with branch retinal vein occlusion had better visual outcomes and decreased macular edema following intravitreal injection of aflibercept compared with laser treatment.

How does any of this relate to ophthalmology? In our offices, we don’t face dramatic this-or-that moments of choice that define us in the way these young men were defined by their decision. For ophthalmologists there is always only one option-to do whatever is in the best interest of our patients.

A topical product (PresbiDrops, FEPASAET Group) that provides sustained pupil constriction can safely and effectively increase near and distance UCVA in properly selected presbyopic patients.

An investigational corneal inlay for presbyopia called the Raindrop had good near visual acuity results and patient satisfaction in a group of active patients.

Use of a home monitoring device to monitor patients at high risk for wet age-related macular degeneration may have a considerable public health impact over time.

Improvement in patients’ assessment of visual function was reported after treatment with intravitreal ocriplasmin for vitreomacular adhesion.

When vetting candidate for an optical manager position, it is often more important to identify managers with the right leadership profile than those with technical competence.

Treatment with ranibizumab is safe and efficacious for currently licensed indications, according to an interim analysis of data from the LUMINOUS Study.

The advent of gene therapy poses a new area of drug development for inherited and acquires ocular disorders.